Retatrutide for severe obesity and serious complications
Treatments studied
Part of Hormones & metabolism clinical trials.
This program provides access to an investigational weight-loss drug called retatrutide for people with severe obesity who have serious health complications and have not gotten enough help from current therapies. If you qualify, you may be able to receive this treatment while it is being studied.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your BMI (a measure of body size) is 35 or higher, and you have already tried and tolerated the highest dose of a weight-management medicine without enough success.
- You have two or more serious or life-threatening health problems caused by obesity, and you are currently getting treatment for them.
- You cannot join a clinical trial of retatrutide or a similar experimental drug.
- You have discussed weight-loss surgery (bariatric surgery) with your doctor as an option.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This study tests a new medication called tirzepatide, given at carefully adjusted doses, to help people with obesity lose weight while reducing unwanted side effects. Tirzepatide is a newer injectable medicine that helps control appetite and blood sugar.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.